Viewing Study NCT01244750


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2025-12-27 @ 8:15 PM
Study NCT ID: NCT01244750
Status: COMPLETED
Last Update Posted: 2022-06-30
First Post: 2010-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module